...
首页> 外文期刊>Birdem Medical Journal >Pattern of dyslipidemia among patients with subclinical hypothyroidism and its relation with thyroid stimulating hormone
【24h】

Pattern of dyslipidemia among patients with subclinical hypothyroidism and its relation with thyroid stimulating hormone

机译:患有亚临床甲状腺功能亢进的患者血脂血症的模式及其与甲状腺刺激激素的关系

获取原文
           

摘要

Background: The relationship between subclinical hypothyroidism (SCH) and dyslipidemia is still debatable about whether SCH is constantly associated with lipid disorder. The aim of this study was to assess the lipid abnormalities in patients with SCH and to evaluate the relation between thyroid stimulating hormone (TSH) and lipid profile.Methods: This cross-sectional observational study was conducted in outpatient department (OPD) of the Hormone and Diabetes Clinic at MARKS Medical College amp; Hospital in Dhaka, Bangladesh from May 2018 to October 2019. A total of 308 subjects (age 30 - 60 years) were included in this study using covenience sampling. Among them, 156 were diagnosed case of SCH, while 152 were euthyroid healthy individuals in control group (matched for age, gender and weight). Laboratory test included serum TSH and free thyroxine (FT4) and fasting lipid profile. Data were analyzed using SPSS version 18 statistical software.Results: In this study, dyslipidemia was more prevalent in patients with SCH compared to control group [p<0.001]. SCH group showed altered lipid profile i.e. significantly higher serum total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), triglycerides (TGs) and lower high density lipoprotein cholesterol (HDL-C) when compared with the euthyroid subjects [p < 0.05 for each]. Pearson’s correlation coefficient for the relationships between serum TSH and lipid level showed that TSH levels were positively correlated with TC, LDL-C, TG and negatively correlated with HDL-C in patients with SCH [p < 0.05 for each].Conclusions: Dyslipidemia is a common feature in SCH compared to euthyroid controls. The study showed that TSH level was positively correlated with TC, LDL-C, TG and negatively correlated with HDL-C. SCH should be a matter for further investigation because dyslipidemia is associated with this thyroid disorder.
机译:背景:亚临床甲状腺功能减退症(SCH)和血脂过度血症之间的关系仍然是关于SCH是否与脂质障碍症不断相关的缺乏争论。本研究的目的是评估SCH患者的脂质异常,并评估甲状腺刺激激素(TSH)和脂质剖面之间的关系。方法:这种横截面观察研究是在激素的门诊部(OPD)中进行的和糖尿病诊所在Marks Medical College AMP;从2018年5月到2019年5月到2019年5月的达卡医院。本研究中,共有308名受试者(30至60岁)使用契约抽样。其中,156例被诊断为SCH,而152则在对照组中进行治疗健康个体(符合年龄,性别和体重)。实验室测试包括血清TSH和游离甲状腺素(FT4)和空腹脂质曲线。使用SPSS版本18统计软件进行分析数据SCH组显示出改变的脂质型材,即在与Euthyroid受试者相比[P <每个] 0.05]。 Pearson对血清TSH和脂质水平之间的关系的相关系数表明,TSH水平与TC,LDL-C,TG和SCH患者的HDL-C呈呈正相关[P <0.05]。结论:血脂血症是与Euthyroid控制相比Sch的常见特征。该研究表明,TSH水平与TC,LDL-C,TG呈正相关,并与HDL-C负相关。 SCH应该是进一步调查的问题,因为血脂血症与这种甲状腺障碍有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号